Mukesh Ambani’s Reliance Life Sciences Seeks Nod For Covid Vaccine Trial: Report

New Delhi: Billionaire Mukesh Ambani-owned pharma firm Reliance Life Sciences has reportedly received regulatory approval to conduct clinical trials of its Covid-19 vaccine.The Subject Expert Committee (SEC), which advises the drug regulator on vaccines and new drugs, is said to have reviewed its application on Thursday and given its approval.READ: What Is Antibody Test And… Continue reading Mukesh Ambani’s Reliance Life Sciences Seeks Nod For Covid Vaccine Trial: Report

Most Indians Experienced No Or Mild Side Effects After Receiving 2 Doses, Says Study

New Delhi: The COVID-19 vaccines available in India are an important weapon against the nation’s battle against the Coronavirus pandemic. While more and more citizens get inoculated, people are seeking information about side effects experienced post vaccination.Taking cognisance of these concerns, LocalCircles conducted a nationwide survey to better understand what citizens have experienced after 1st… Continue reading Most Indians Experienced No Or Mild Side Effects After Receiving 2 Doses, Says Study

Children Above 12 Years With Comorbidities To Be Prioritised For Covid Vaccination In India Informs Govt Panel Chief

New Delhi: With the third wave of Covid likely to affect children, all those above the age of 12 with comorbidities will be prioritised for vaccination, according to the government advisory committee National Immunization Technical Advisory Group (NTAGI).While talking to CNBC-TV18, NTAGI chief NK Arora informed that a certain supply of Zydus Cadila’s Zycov-D vaccine,… Continue reading Children Above 12 Years With Comorbidities To Be Prioritised For Covid Vaccination In India Informs Govt Panel Chief

In A First, FDA Grants Full Approval To Pfizer-BioNTech’s COVID-19 Vaccine Found 91 Percent Effective Against Virus

New Delhi: The US Food and Drug Administration (US FDA) on Monday gave full approval to Pfizer-BioNTech’s COVID-19 vaccine, making it the first vaccine to receive such approval.The US health regulator had in December 2020 given emergency use authorisation (EAU) for the vaccine developed by US-based Pfizer and its German partner BioNTech.ALSO READ | EXPLAINED… Continue reading In A First, FDA Grants Full Approval To Pfizer-BioNTech’s COVID-19 Vaccine Found 91 Percent Effective Against Virus

Cadila Healthcare Share Price Rises Nearly 8 Percent After ZyCoV-D COVID-19 Vaccine Gets India Emergency Use Nod

New Delhi: Three days after the Narendra Modi government approved Cadila Healthcare’s Covid-19 vaccine for emergency use in adults and children aged 12 years and above, the company’s shares jumped 7.9 per cent on Monday, reports said.Zydus Cadila’s three-dose ZyCoV-D vaccine is the world’s first DNA shot against Covid-19, and it has been developed in… Continue reading Cadila Healthcare Share Price Rises Nearly 8 Percent After ZyCoV-D COVID-19 Vaccine Gets India Emergency Use Nod

Pfizer Covid Vaccine Could Get FDA ‘Full Approval’ By Monday. Know What This Means

New Delhi: The US Food and Drug Administration (FDA) is likely to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, The New York Times has reported quoting “people familiar with the agency’s planning”.While no official statement on this has come from the FDA yet, the NYT report said regulators were still working through a “substantial amount… Continue reading Pfizer Covid Vaccine Could Get FDA ‘Full Approval’ By Monday. Know What This Means

Zydus Cadila’s COVID Vaccine Price To Be Revealed Next Week, Supply Begins In Mid-Sept: Group MD

New Delhi: Sharvil Pankajbhai Patel, Managing Director of Cadila Healthcare Ltd, on Saturday informed about the plans to roll out the ZyCOV-D vaccine doses after the drugmaker received the nod for the same.The Drug Controller General of India had on Friday granted emergency use approval for ZyCoV-D, the COVID-19 vaccine by Zydus Cadila that is the… Continue reading Zydus Cadila’s COVID Vaccine Price To Be Revealed Next Week, Supply Begins In Mid-Sept: Group MD

Covid-19 Vaccine Will Be Available For Children By Next Month- NIV-ICMR

New Delhi: Indian Council of Medical Research (ICMR)’s National Institute of Virology (NIV) Director Priya Abraham has expressed hope that Covid-19 vaccine will be available for the children by next month.Abraham said phase II and III trials of Covaxin are presently  going on for the children in the age group of 2 to 18 years.Commenting… Continue reading Covid-19 Vaccine Will Be Available For Children By Next Month- NIV-ICMR

UK Health Regulator Approves Moderna Shot For Children Aged 12 To 17 Years

New Delhi: Britain’s health regulator has approved Moderna Inc’s Covid-19 vaccine for use in the children aged 12 to 17 years. The approval comes more than two months after Pfizer Inc and German partner BioNTech’s Covid-19 vaccine got regulatory nod for use in children aged 12 to 15, Reuters reported. Moderna’s Covid-19 vaccine is currently… Continue reading UK Health Regulator Approves Moderna Shot For Children Aged 12 To 17 Years

Stockpiling Covid Vaccine Booster Doses Rich Countries Will Cause More Deaths Worldwide GAVI

A group of experts has urged developed countries to fulfill their responsibilities towards humanity by not stockpiling COVID-19 vaccines for themselves. The head of the Oxford Vaccine Group said more people worldwide could die due to COVID-19 if leaders did not share doses of the vaccine with third-world countries.  GAVI vaccine alliance Chief Executive Set… Continue reading Stockpiling Covid Vaccine Booster Doses Rich Countries Will Cause More Deaths Worldwide GAVI